{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:16:08Z","timestamp":1776690968627,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,31]]},"DOI":"10.7759\/cureus.27521","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T21:57:35Z","timestamp":1659304655000},"source":"Crossref","is-referenced-by-count":1,"title":["Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits"],"prefix":"10.7759","author":[{"given":"Jared H","family":"Hara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley I","family":"Gutiontov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari J","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander T","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Gooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everett E","family":"Vokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T","family":"Ginat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J","family":"Haraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Juloori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.3870","article-title":"Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers","volume":"31","author":"Chaturvedi AK","year":"2013","unstructured":"Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al.. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013, 31:4550-9. 10.1200\/JCO.2013.50.3870","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.01.018","article-title":"Re-evaluation of ipsilateral radiation for T1-T2N0-N2b tonsil carcinoma at the Princess Margaret Hospital in the human papillomavirus era, 25\u00a0years later","volume":"98","author":"Huang SH","year":"2017","unstructured":"Huang SH, Waldron J, Bratman SV, et al.. Re-evaluation of ipsilateral radiation for T1-T2N0-N2b tonsil carcinoma at the Princess Margaret Hospital in the human papillomavirus era, 25\u00a0years later. Int J Radiat Oncol Biol Phys. 2017, 98:159-69. 10.1016\/j.ijrobp.2017.01.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25776","article-title":"Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer - approach with caution","volume":"41","author":"Maskell D","year":"2019","unstructured":"Maskell D, Buckley H, Sission K, Roques T, Geropantas K. Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer - approach with caution. Head Neck. 2019, 41:2937-46. 10.1002\/hed.25776","journal-title":"Head Neck"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28938","article-title":"Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life","volume":"120","author":"Spencer CR","year":"2014","unstructured":"Spencer CR, Gay HA, Haughey BH, et al.. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life. Cancer. 2014, 120:3994-4002. 10.1002\/cncr.28938","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy522","article-title":"OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer","volume":"30","author":"Seiwert TY","year":"2019","unstructured":"Seiwert TY, Foster CC, Blair EA, et al.. OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Ann Oncol. 2019, 30:297-302. 10.1093\/annonc\/mdy522","journal-title":"Ann Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2020.01.004","article-title":"Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma","volume":"21","author":"McDowell L","year":"2020","unstructured":"McDowell L, Casswell G, Bressel M, et al.. Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma. Clin Transl Radiat Oncol. 2020, 21:85-90. 10.1016\/j.ctro.2020.01.004","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(01)01613-3","article-title":"The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region","volume":"51","author":"O'Sullivan B","year":"2001","unstructured":"O'Sullivan B, Warde P, Grice B, et al.. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys. 2001, 51:332-343. 10.1016\/s0360-3016(01)01613-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26492","article-title":"Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary","volume":"43","author":"Tsai CJ","year":"2021","unstructured":"Tsai CJ, Galloway TJ, Margalit DN, et al.. Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary. Head Neck. 2021, 43:392-406. 10.1002\/hed.26492","journal-title":"Head Neck"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2020.11.011","article-title":"Refining guidelines regarding unilateral treatment in patients with well-lateralized squamous cell carcinoma of the palatine tonsil and multiple positive nodes or extranodal extension","volume":"11","author":"Amdur RJ","year":"2021","unstructured":"Amdur RJ, Harari PM, Dziegielewski PT, Mendenhall WM. Refining guidelines regarding unilateral treatment in patients with well-lateralized squamous cell carcinoma of the palatine tonsil and multiple positive nodes or extranodal extension. Pract Radiat Oncol. 2021, 11:e247-51. 10.1016\/j.prro.2020.11.011","journal-title":"Pract Radiat Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw051","article-title":"Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer","volume":"27","author":"Villaflor VM","year":"2016","unstructured":"Villaflor VM, Melotek JM, Karrison TG, et al.. Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Ann Oncol. 2016, 27:908-13. 10.1093\/annonc\/mdw051","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105566","article-title":"Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience","volume":"122","author":"Rosenberg AJ","year":"2021","unstructured":"Rosenberg AJ, Agrawal N, Pearson A, et al.. Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience. Oral Oncol. 2021, 122:105566. 10.1016\/j.oraloncology.2021.105566","journal-title":"Oral Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom SS","year":"2021","unstructured":"Yom SS, Torres-Saavedra P, Caudell JJ, et al.. Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002). J Clin Oncol. 2021, 39:956-65. 10.1200\/JCO.20.03128","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2012.12.006","article-title":"Unilateral neck irradiation for well-lateralized oropharyngeal cancer","volume":"106","author":"Al-Mamgani A","year":"2013","unstructured":"Al-Mamgani A, van Rooij P, Fransen D, Levendag P. Unilateral neck irradiation for well-lateralized oropharyngeal cancer. Radiother Oncol. 2013, 106:69-73. 10.1016\/j.radonc.2012.12.006","journal-title":"Radiother Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30931","article-title":"Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil","volume":"123","author":"Chin RI","year":"2017","unstructured":"Chin RI, Rao YJ, Hwang MY, et al.. Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil. Cancer. 2017, 123:4594-607. 10.1002\/cncr.30931","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.06.1975","article-title":"Unilateral radiotherapy for the treatment of tonsil cancer","volume":"83","author":"Chronowski GM","year":"2012","unstructured":"Chronowski GM, Garden AS, Morrison WH, et al.. Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys. 2012, 83:204-9. 10.1016\/j.ijrobp.2011.06.1975","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.11.053","article-title":"Ipsilateral tonsil chemoradiation: improved toxicity compared to bilateral radiation and effective rates of local-regional control: definitive management of head-and-neck squamous cell carcinoma","volume":"88","author":"Cramer CK","year":"2014","unstructured":"Cramer CK, Palta M, Patel P, Brizel DM. Ipsilateral tonsil chemoradiation: improved toxicity compared to bilateral radiation and effective rates of local-regional control: definitive management of head-and-neck squamous cell carcinoma. Int J Radiat Biol. 2014, 88:477. 10.1016\/j.ijrobp.2013.11.053","journal-title":"Int J Radiat Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2015.03.013","article-title":"Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach","volume":"51","author":"Dan TD","year":"2015","unstructured":"Dan TD, Raben D, Schneider CJ, et al.. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach. Oral Oncol. 2015, 51:616-21. 10.1016\/j.oraloncology.2015.03.013","journal-title":"Oral Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24806","article-title":"Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization","volume":"39","author":"Hu KS","year":"2017","unstructured":"Hu KS, Mourad WF, Gamez M, et al.. Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization. Head Neck. 2017, 39:1647-54. 10.1002\/hed.24806","journal-title":"Head Neck"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.11.048","article-title":"Unilateral radiation therapy in node-positive patients with lateralized tonsillar carcinoma: definitive management of head-and-neck squamous cell carcinoma","volume":"88","author":"Hwang MY","year":"2013","unstructured":"Hwang MY, Spencer CR, Patel P, et al.. Unilateral radiation therapy in node-positive patients with lateralized tonsillar carcinoma: definitive management of head-and-neck squamous cell carcinoma. Int J Radiat Biol. 2013, 88:475. 10.1016\/j.ijrobp.2013.11.048","journal-title":"Int J Radiat Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-8140(99)00051-1","article-title":"Cancer of the tonsil: the results of ipsilateral radiation treatment","volume":"51","author":"Jackson SM","year":"1999","unstructured":"Jackson SM, Hay JH, Flores AD, Weir L, Wong FL, Schwindt C, Baerg B. Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol. 1999, 51:123-8. 10.1016\/s0167-8140(99)00051-1","journal-title":"Radiother Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.06.005","article-title":"Morbidity after ipsilateral radiotherapy for oropharyngeal cancer","volume":"85","author":"Jensen K","year":"2007","unstructured":"Jensen K, Overgaard M, Grau C. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiother Oncol. 2007, 85:90-7. 10.1016\/j.radonc.2007.06.005","journal-title":"Radiother Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-8140(99)00179-6","article-title":"Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation","volume":"54","author":"Kagei K","year":"2000","unstructured":"Kagei K, Shirato H, Nishioka T, et al.. Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol. 2000, 54:117-21. 10.1016\/s0167-8140(99)00179-6","journal-title":"Radiother Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-015-3725-3","article-title":"Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil","volume":"273","author":"Kennedy WR","year":"2016","unstructured":"Kennedy WR, Herman MP, Deraniyagala RL, et al.. Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Eur Arch Otorhinolaryngol. 2016, 273:2151-6. 10.1007\/s00405-015-3725-3","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2013.31.2.66","article-title":"Long-term results of ipsilateral radiotherapy for tonsil cancer","volume":"31","author":"Koo TR","year":"2013","unstructured":"Koo TR, Wu HG. Long-term results of ipsilateral radiotherapy for tonsil cancer. Radiat Oncol J. 2013, 31:66-71. 10.3857\/roj.2013.31.2.66","journal-title":"Radiat Oncol J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.322","article-title":"Patterns of relapse in squamous cell carcinoma of the tonsil - unilateral vs. bilateral radiation in the HPV-era","volume":"7","author":"Ye A","year":"2015","unstructured":"Ye A, Bradley KL, Kader H, Wu J, Hay JH. Patterns of relapse in squamous cell carcinoma of the tonsil - unilateral vs. bilateral radiation in the HPV-era. Cureus. 2015, 7:e322. 10.7759\/cureus.322","journal-title":"Cureus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.10.023","article-title":"Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach","volume":"74","author":"Rusthoven KE","year":"2009","unstructured":"Rusthoven KE, Raben D, Schneider C, Witt R, Sammons S, Raben A. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. Int J Radiat Oncol Biol Phys. 2009, 74:1365-70. 10.1016\/j.ijrobp.2008.10.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23297","article-title":"Tonsillar cancer: the Peter MacCallum experience with unilateral and bilateral irradiation","volume":"36","author":"Liu C","year":"2014","unstructured":"Liu C, Dutu G, Peters LJ, Rischin D, Corry J. Tonsillar cancer: the Peter MacCallum experience with unilateral and bilateral irradiation. Head Neck. 2014, 36:317-22. 10.1002\/hed.23297","journal-title":"Head Neck"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2014.06.019","article-title":"Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil","volume":"50","author":"Lynch J","year":"2014","unstructured":"Lynch J, Lal P, Schick U, Nutting CM, Newbold K, Harrington K, Bhide S. Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Oral Oncol. 2014, 50:901-6. 10.1016\/j.oraloncology.2014.06.019","journal-title":"Oral Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24541","article-title":"Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil","volume":"39","author":"Rackley TP","year":"2017","unstructured":"Rackley TP, Namelo WC, Palaniappan N, Cole N, Owens DM, Evans M. Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil. Head Neck. 2017, 39:17-23. 10.1002\/hed.24541","journal-title":"Head Neck"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2016.425","article-title":"Comparison of the clinical outcomes of patients with squamous cell carcinoma of the tonsil receiving postoperative ipsilateral versus bilateral neck radiotherapy: a propensity score matching analysis (KROG 11-07)","volume":"49","author":"Kim Y","year":"2017","unstructured":"Kim Y, Cho KH, Moon SH, et al.. Comparison of the clinical outcomes of patients with squamous cell carcinoma of the tonsil receiving postoperative ipsilateral versus bilateral neck radiotherapy: a propensity score matching analysis (KROG 11-07). Cancer Res Treat. 2017, 49:1097-105. 10.4143\/crt.2016.425","journal-title":"Cancer Res Treat"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2019.1186","article-title":"Occult nodal disease and occult extranodal extension in patients with oropharyngeal squamous cell carcinoma undergoing primary transoral robotic surgery with neck dissection","volume":"145","author":"McMullen CP","year":"2019","unstructured":"McMullen CP, Garneau J, Weimar E, et al.. Occult nodal disease and occult extranodal extension in patients with oropharyngeal squamous cell carcinoma undergoing primary transoral robotic surgery with neck dissection. JAMA Otolaryngol Head Neck Surg. 2019, 145:701-7. 10.1001\/jamaoto.2019.1186","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.105165","article-title":"Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: an international practice pattern survey","volume":"114","author":"de Almeida JR","year":"2021","unstructured":"de Almeida JR, Seungyeon Kim V, O'Sullivan B, et al.. Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: an international practice pattern survey. Oral Oncol. 2021, 114:105165. 10.1016\/j.oraloncology.2020.105165","journal-title":"Oral Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.6011","article-title":"Nivolumab, nabpaclitaxel, and carboplatin followed by risk\/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial","volume":"39","author":"Rosenberg A","year":"2021","unstructured":"Rosenberg A, Agrawal N, Pearson AT, et al.. Nivolumab, nabpaclitaxel, and carboplatin followed by risk\/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial. J Clin Oncol. 2021, 39:6011. 10.1200\/JCO.2021.39.15_suppl.6011","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09146-z","article-title":"Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment","volume":"22","author":"Rosenberg AJ","year":"2022","unstructured":"Rosenberg AJ, Izumchenko E, Pearson A, et al.. Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022, 22:17. 10.1186\/s12885-021-09146-z","journal-title":"BMC Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.09.012","article-title":"MC1675, a phase III evaluation of de-escalated adjuvant radiation therapy (DART) vs. standard adjuvant treatment for human papillomavirus associated oropharyngeal squamous cell carcinoma","volume":"111","author":"Ma DM","year":"2021","unstructured":"Ma DM, Price K, Moore EJ, et al.. MC1675, a phase III evaluation of de-escalated adjuvant radiation therapy (DART) vs. standard adjuvant treatment for human papillomavirus associated oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2021, 111:1324. 10.1016\/j.ijrobp.2021.09.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.07.023","article-title":"SPECT\/CT-guided elective nodal irradiation for head and neck cancer: estimation of clinical benefits using NTCP models","volume":"130","author":"de Veij Mestdagh PD","year":"2019","unstructured":"de Veij Mestdagh PD, Janssen T, Lamers E, et al.. SPECT\/CT-guided elective nodal irradiation for head and neck cancer: estimation of clinical benefits using NTCP models. Radiother Oncol. 2019, 130:18-24. 10.1016\/j.radonc.2018.07.023","journal-title":"Radiother Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.03.012","article-title":"SPECT\/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: a potentially practice-changing approach","volume":"147","author":"de Veij Mestdagh PD","year":"2020","unstructured":"de Veij Mestdagh PD, Walraven I, Vogel WV, et al.. SPECT\/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: a potentially practice-changing approach. Radiother Oncol. 2020, 147:56-63. 10.1016\/j.radonc.2020.03.012","journal-title":"Radiother Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92799-characterizing-lymph-node-burden-with-elective-unilateral-neck-irradiation-in-human-papillomavirus-positive-tonsil-squamous-cell-carcinoma-defining-the-upper-limits","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:02Z","timestamp":1707508022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92799-characterizing-lymph-node-burden-with-elective-unilateral-neck-irradiation-in-human-papillomavirus-positive-tonsil-squamous-cell-carcinoma-defining-the-upper-limits"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,31]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.27521","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,31]]}}}